Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
nephropathy
Pharma
Roche heads to regulators with new autoimmune win for Gazyva
Continuing the reinvention of its cancer drug Gazyva in immune-mediated diseases, Roche is touting new data in primary membranous nephropathy.
Fraiser Kansteiner
Feb 17, 2026 10:15am
Travere's bid to gain new approval for Filspari hits FDA hitch
Jan 14, 2026 11:22am
RemeGen's telitacicept result sets up IgAN submission in China
Aug 27, 2025 11:13am
Novartis rides IgAN trioka to trial wins in rare kidney diseases
May 28, 2024 11:20am
